NDC 72582-005

LENIFEN

Lenifen

LENIFEN is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Contrad Swiss Sa. The primary component is Avenanthramides; Glycerin.

Product ID72582-005_87ea6aa3-43ba-11f8-e053-2995a90a7b01
NDC72582-005
Product TypeHuman Otc Drug
Proprietary NameLENIFEN
Generic NameLenifen
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-03-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart347
Labeler NameCONTRAD SWISS SA
Substance NameAVENANTHRAMIDES; GLYCERIN
Active Ingredient Strength0 g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72582-005-02

1 TUBE in 1 CARTON (72582-005-02) > 1 TUBE in 1 TUBE > 20 g in 1 TUBE
Marketing Start Date2019-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72582-005-02 [72582000502]

LENIFEN CREAM
Marketing CategoryOTC monograph not final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-03-01

Drug Details

Active Ingredients

IngredientStrength
AVENANTHRAMIDES.05 g/100g

Trademark Results [LENIFEN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LENIFEN
LENIFEN
87830680 not registered Dead/Abandoned
Contrad Swiss SA
2018-03-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.